COMMUNIQUÉS West-GlobeNewswire

Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference

05/03/2018 - 14:00

DALLAS and FORT WORTH, Texas, March 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]

Onconova Therapeutics Announces License Agreement with Pint Pharma to Commercialize Rigosertib for Treatment of Myelodysplastic Syndromes in Latin America

05/03/2018 - 14:00

• Pint Pharma to Make Upfront Investment in Onconova • Onconova also Eligible to Receive up to $42.75 Million in Regulatory and Sales Milestones NEWTOWN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, [...]

Krystal Biotech, Inc. to Present at the 30th Annual ROTH Conference

05/03/2018 - 14:00

PITTSBURGH, March 05, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS ), a gene therapy company advancing “off-the-shelf,” treatments for dermatological diseases, today announced that Krish Krishnan, Chief [...]

pSivida To Present at the 30th Annual ROTH Conference

05/03/2018 - 14:00

WATERTOWN, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President [...]

Todos Medical initiates clinical trial of its blood test for breast cancer in Kaplan Hospital, Rehovot, Israel for subjects undergoing breast cancer screening

05/03/2018 - 14:00

REHOVOT, Israel, March 05, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) ( http://www.Todosmedical.com ) today announced the initiation of its first blinded clinical trial for TM-B1 – a simple blood test [...]

Avinger Announces Participation in Cowen and Company 38th Annual Health Care Conference

05/03/2018 - 14:00

REDWOOD CITY, Calif, March 05, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will be [...]

Jounce Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference

05/03/2018 - 14:00

CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

PhaseBio Announces Appointments to Board of Directors

05/03/2018 - 14:00

MALVERN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced the appointment of [...]

Synergy CHC Corp. to Present at 30th Annual Roth Conference on March 13th

05/03/2018 - 14:00

Westbrook, Maine, March 05, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ), a leading omni-channel consumer health and beauty company, announced today that Jeffrey Kadanoff, Chief Financial Officer, is [...]

Immunomedics to Present at Cowen and Company 38th Annual Health Care Conference

05/03/2018 - 14:00

MORRIS PLANS, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that Michael Pehl, President and Chief Executive Officer, will present an [...]

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

05/03/2018 - 14:00

WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that company management will participate in the following investor conferences: Cowen and Company 38 th [...]

Emerald Health Therapeutics and Village Farms International Announce Cannabis Cultivation License for 1.1 Million Ft2 Delta 3 Greenhouse Operation

05/03/2018 - 14:00

VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSX-V: EHT ) (OTCQX:EMHTF) and Village Farms International, Inc. (Village Farms) (TSX: VFF ) (OTCQX:VFFIF) [...]

Avenue Therapeutics to Present at March Investor Conferences

05/03/2018 - 14:00

NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced that Lucy Lu, M [...]

Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints

05/03/2018 - 13:59

Company expects to discontinue the program Conference call and webcast today at 8:30 a.m. ET / 5:30 a.m. PT MENLO PARK, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical [...]

Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018

05/03/2018 - 13:50

FRAMINGHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]

Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit

05/03/2018 - 13:45

CHARLESTON, S.C., March 05, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (the “Company” or “Aeterna Zentaris”) (NASDAQ: AEZS ) and (TSX: AEZS ) announced today that the United States District Court for the District of [...]

Strongbridge Biopharma plc to Present KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis Data at the 2018 American Academy of Neurology Annual Meeting

05/03/2018 - 13:30

~ Post-Hoc Analysis of Phase 3 Placebo-Controlled Study of KEVEYIS Showed Adolescents had Similar Improvements in Short-Term Attack Rates as Adults ~ ~ Pooled Analysis of Two Phase 3 Studies Further Demonstrate the [...]

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2018

05/03/2018 - 13:30

CRANBURY, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced upcoming presentations at two investor conferences in March. John F. Crowley, Chairman and Chief Executive Officer, [...]

FDA Approves PDUFA Fee Waiver for Gimoti™ New Drug Application

05/03/2018 - 13:30

SOLANA BEACH, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the U.S. [...]